IVI RMA announced on November 8 that it acquired the North American operations of Eugin Group, a network of fertility clinics across Europe, North and South America. The acquisition includes the Boston IVF fertility network and Toronto-based TRIO. The seller is Fresenius Inc., a European network of dialysis centers.
Boston IVF is based in Boston, Massachusetts and has 19 centers across Massachusetts, Maine, New Hampshire, New York, Idaho, Indiana, Ohio, Rhode Island and Utah. It has a team of 25 fertility specialists.
TRIO is based out of Toronto, Ontario and has a team of 18 fertility specialists.
IVI RMA is one of the world’s leading reproductive medicine groups. IVI RMA employs more than 4,400 people across more than 150 locations in 14 countries, including the United States, Spain and the United Kingdom.
The strategic additions will grow IVI RMA to become a leading fertility group in North America. The acquisition will add more than 600 employees across 13 labs and 32 satellite offices to IVI RMA’s network of 10 labs and 29 satellites in North America. The financial terms of the acquisition were not disclosed.
According to data captured in the LevinPro HC database, this transaction is the 450th Physician Medical Groups acquisition of the year, and 25th in the OB/GYN specialty.
